Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
about
sameAs
Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamilyOxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A)Network analysis of human glaucomatous optic nerve head astrocytes.Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease.Neurodegeneration and motor dysfunction in mice lacking cytosolic and mitochondrial aldehyde dehydrogenases: implications for Parkinson's disease.Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency.Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretionInduction of a unique isoform of the NCOA7 oxidation resistance gene by interferon β-1b.Prioritizing candidate disease metabolites based on global functional relationships between metabolites in the context of metabolic pathways.Characterization of Aldh2 (-/-) mice as an age-related model of cognitive impairment and Alzheimer's diseaseRole of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism.Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly.Advanced glycation end-products (AGEs): involvement in aging and in neurodegenerative diseases.The human brain produces fructose from glucose.Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.Aldehyde dehydrogenase (ALDH) in Alzheimer's and Parkinson's disease.Proteomic identification of differentially expressed proteins in the aging murine olfactory system and transcriptional analysis of the associated genes.Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer's disease.High glucose-induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32.Mitochondrial oxidation of 4-hydroxy-2-nonenal in rat cerebral cortex.Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum.Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells.Deuterium-reinforced polyunsaturated fatty acids improve cognition in a mouse model of sporadic Alzheimer's disease.Escherichia coli YqhD exhibits aldehyde reductase activity and protects from the harmful effect of lipid peroxidation-derived aldehydes.Expression of regulatory proteins in choroid plexus changes in early stages of Alzheimer disease.Proteomic study of neuron and astrocyte cultures from senescence-accelerated mouse SAMP8 reveals degenerative changes.Blastomere biopsy influences epigenetic reprogramming during early embryo development, which impacts neural development and function in resulting mice.
P2860
Q24655095-52505948-684B-4D8E-9FA7-FF7DC0FED785Q28582711-946EDD4C-3ABC-420A-9275-B01248002E13Q33442021-FC47B1C4-D2BC-4A45-B512-F6AC9EA44666Q33915362-E074FB38-3045-4FA6-A902-683800CC3149Q34181738-934AD9E4-9C70-4BAF-A352-0295E47902FFQ34278712-5B57299C-188A-4538-9D02-B01AD7419CF5Q35097354-5368AE1E-24E2-4ED4-807A-B4BA859386D5Q35148941-EBA9008D-33DB-40D1-83A5-0EF2234A7005Q35231088-74DDA336-C194-4197-883D-ACDFF669BF66Q35537887-4A94BE1F-0664-48C8-8D1E-78059443A327Q35828024-CAEF36CF-038E-4810-8A3F-AD0D7402BCF5Q36473605-B7171CB0-E57C-4472-98AA-7D13EA369B4BQ37002833-B69B68AA-82B6-47E2-A4BB-92CAD4609C9FQ37646879-576D6F75-686E-4D7E-A742-33D72CF6149EQ38050263-44468E02-D16C-4A95-AD99-FC3F36FC0C50Q38258298-008EC309-96E7-4EB3-AED7-4EAA39963C42Q38324024-2BB2E477-C0CD-40AB-B05B-B9E2E30837FCQ38930361-56EF03E4-1CE9-4371-B386-A74778BA6B51Q40262190-56ED3942-71B5-41AC-BEAD-F9ACA5C17577Q40667059-063C4231-F9A6-4441-A72A-DF7AF827FD04Q44309693-C6344492-E8E2-458D-AB8D-F125556F0CA6Q44326525-2F52499B-F4B5-48B5-9E08-BDCE755CB312Q46287807-98C446A1-43C2-445C-B0E8-1A50A93C22F7Q46796808-548A2AD9-420E-41DF-B21E-73DD83F140AAQ48288518-63E3C5BF-58BA-4CC6-9672-1E01CF96BCA5Q48465039-37293942-68EC-4B59-AE7F-2B592A9A266CQ49031031-CFA8976D-1817-4D84-B2BC-192F564A9688
P2860
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
@ast
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
@en
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
@nl
type
label
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
@ast
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
@en
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
@nl
prefLabel
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
@ast
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
@en
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
@nl
P2093
P2860
P356
P1476
Expression and activities of aldo-keto oxidoreductases in Alzheimer disease
@en
P2093
M J Picklo
T J Montine
W R Markesbery
P2860
P304
P356
10.1093/JNEN/60.7.686
P407
P577
2001-07-01T00:00:00Z